Will Strong Asceniv Sales Drive ADMA Biologics Further?

• click to rate

  Posted by Two Blokes Jun 27 - Filed in Stock - 6 views
  
  ADMA rides on record Asceniv sales and FDA-backed yield boost, but valuation concerns and EPS downgrades cloud its outlook.